Synagis palivizumab 50mg/0.5 mL Single-Dose Vial Santare chhilaka Packaged in a convenient set

Packaged in a convenient set of five 2 mL vials

forcing the extra insulin (and bubbles) back into the vial

Brand: ProCare

Absorbs exudate quickly

Synagis palivizumab 50mg/0.5 mL Single-Dose Vial Santare chhilaka Packaged in a convenient setSynagis palivizumab 50mg 0. 5 mL Single Dose Vial is a highly effective medication used for the prevention of serious respiratory tract infections caused by the respiratory syncytial virus (RSV) in infants and children. RSV is a common virus that can lead to severe respiratory infections in young children, particularly those with weakened immune systems. Synagis palivizumab, with its active ingredient 50mg of palivizumab, is administered by injection